Concepedia

Rakesh Gaur

RG

29

Publications

5.3K

Citations

24

H-Index

1986

Active since

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Moffitt Cancer Center

Memorial Sloan Kettering Cancer Center

Cleveland Clinic

RTOG Foundation

Rakesh Gaur is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, oncology, and cancer therapeutics.

ORCID

Top concepts

Publications per year

1986–2020

29

Publications

29

Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study

Jeffrey D. Bradley, Rebecca Paulus, Ritsuko Komaki et al. · The Lancet Oncology · 2015 · 2K citations · Full text

, , +6

Bevacizumab Added to Neoadjuvant Chemotherapy for Breast Cancer

Harry D. Bear, Gong Tang, Priya Rastogi et al. · New England Journal of Medicine · 2012 · 464 citations · Full text

Complete Surgical Excision Is Essential for the Management of Patients With Breast Implant–Associated Anaplastic Large-Cell Lymphoma

Mark W. Clemens, L. Jeffrey Medeiros, Charles E. Butler et al. · Journal of Clinical Oncology · 2015 · 414 citations · Full text

Phase IB/II Randomized Study of FOLFIRINOX Plus Pegylated Recombinant Human Hyaluronidase Versus FOLFIRINOX Alone in Patients With Metastatic Pancreatic Adenocarcinoma: SWOG S1313

Ramesh K. Ramanathan, Shannon McDonough, Philip A. Philip et al. · Journal of Clinical Oncology · 2019 · 314 citations · Full text

Hematologic Toxicity in RTOG 0418: A Phase 2 Study of Postoperative IMRT for Gynecologic Cancer

Ann H. Klopp, Jennifer Moughan, Lorraine Portelance et al. · International Journal of Radiation Oncology*Biology*Physics · 2013 · 248 citations · Full text

, , +9

Rows per page

1–5 of 29